Day: July 19, 2023

Acumen Announces Pricing of Upsized $130 Million Public Offering

Written by Customer Service on July 19, 2023. Posted in Public Companies.

CHARLOTTESVILLE, Va. and CARMEL, Ind., July 18, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (“Acumen”) (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced the pricing of an upsized underwritten public offering of 16,774,193 shares of its common stock at a price to the public of $7.75 per share. All of the shares are being offered by Acumen. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Acumen, are expected to be approximately $130 million. The offering is expected to close on July 21, 2023, subject to the satisfaction of customary closing conditions. In addition, Acumen has granted the...

Bitcoin Well Announces $2.5 Million Non-Brokered Private Placement

Written by Customer Service on July 19, 2023. Posted in Public Companies.

EDMONTON, Alberta, July 18, 2023 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV:BTCW; OTCQB:BCNWF), the non-custodial fintech business which future-proofs money by making bitcoin useful to everyday people, announces its intention to complete a non-brokered private placement offering (the “Offering“) of up to 41,666,667 units of Bitcoin Well (the “Units”) at a price of $0.06 per Unit for aggregate gross proceeds of up to $2,500,000. The minimum Offering size is $1,000,000, being 16,666,667 Units. Each Unit will be comprised of one common share in the Company (each, a “Common Share” and collectively “Common Shares”) and one common share purchase warrant (each, a “Warrant” and collectively “Warrants”) being exercisable into one Common Share at a price of $0.18 per share...

argenx raises $1.1 billion in gross proceeds in a global offering

Written by Customer Service on July 19, 2023. Posted in Public Companies.

Regulated information — Inside information July 18, 2023, 9:20 PM ET July 19, 2023, 3:20 AM CET Amsterdam, the Netherlands — argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced today the pricing of a global offering of ordinary shares, which may be represented by American Depository Shares (“ADSs”). The global offering is comprised of an offering of ordinary shares represented by ADSs in the United States and certain other countries outside of the European Economic Area and a simultaneous private placement of ordinary shares in the European Economic Area and the United Kingdom. The Company anticipates total gross proceeds of approximately $1.1 billion (approximately €979.6 million) from the sale of 1,580,981 ADSs at...

Refrigerated Transport Market to Surpass 193.32 Billion by 2030 Drives Due to Increasing Number of Small and Large Food Chains

Written by Customer Service on July 19, 2023. Posted in Mergers And Acquisitions.

SkyQuest projects that the refrigerated transport market will attain a USD 193.32 billion value by 2030, with a CAGR of 6.5% over the forecast period (2023-2030). The global refrigerated transport market is anticipated to experience substantial growth in the predictable years, primarily driven by the increasing number of small and large food chains worldwide. The growing presence of big and small food chains demands a reliable and efficient cold chain logistics system to transport perishable goods, including frozen food (raw materials). Westford, USA, July 18, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the refrigerated transport market is experiencing robust growth, primarily fueled by the rise in refrigerated warehouses, pharmaceutical sector expansion, and food and beverage industry advancements. The proliferation of refrigerated...

iQIYI Partners with PubMatic for Programmatic Technology Solutions

Written by Customer Service on July 19, 2023. Posted in Public Companies.

SINGAPORE, July 19, 2023 (GLOBE NEWSWIRE) — PubMatic, (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, and iQIYI International, an on-demand video streaming service providing beloved pan-Asian entertainment to international viewers, today announced an expanded partnership through the implementation of PubMatic’s OpenWrap OTT. As premium over the top (OTT) streaming services embrace programmatic to maximise revenue, expose their inventory to more advertisers and provide a better ad experience for viewers, unified auction solutions are becoming increasingly popular. OpenWrap OTT is PubMatic’s unified auction solution for OTT and connected TV (CTV) publishers. The solution offers publishers:Higher yield through aggregated demand and brand-safe private marketplaces and...

Topicus.com Inc. Announces Release Date for Second Quarter Results

Written by Customer Service on July 19, 2023. Posted in Public Companies.

TORONTO, July 18, 2023 (GLOBE NEWSWIRE) — Topicus.com Inc. (TSXV:TOI) announced today it intends to release its second quarter results on August 3, 2023. The Company’s quarterly results will be disseminated via press release and made available on the Company’s website (www.topicus.com) and SEDAR, after markets close on Thursday, August 3, 2023. About Topicus.com Inc. Topicus’ subordinate voting shares are listed on the Toronto Venture Stock Exchange under the symbol “TOI”. Topicus acquires, manages and builds vertical market software businesses. Contact: Jamal BakshChief Financial Officer 416-861-9677

AIM ImmunoTech Issues Notice that an Unaffiliated Third Party and Organization are Providing False Information Related to Relationship with Company and its Affiliates

Written by Customer Service on July 19, 2023. Posted in Public Companies.

OCALA, Fla., July 18, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today issued a notice that the Company has learned that unknown person(s) and/or organization(s) are claiming to represent AIM ImmunoTech Europe and are using the Company’s name without authorization. Specifically, there is a LinkedIn profile promoting misinformation related to AIM’s ongoing clinical activities, and the profile purports to be linked to the organization Clavinvest. The unauthorized and unaffiliated profile uses AIM’s logo and copyrighted imagery to provide the impression that it has a formal relationship with AIM concerning AIM’s activities with Erasmus Medical Center in the Netherlands and Prof. C.H.J. van Eijck. Among other things, the LinkedIn profile promotes inaccurate information on its relationship...

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Day: July 19, 2023

Acumen Announces Pricing of Upsized $130 Million Public Offering

Bitcoin Well Announces $2.5 Million Non-Brokered Private Placement

argenx raises $1.1 billion in gross proceeds in a global offering

Refrigerated Transport Market to Surpass 193.32 Billion by 2030 Drives Due to Increasing Number of Small and Large Food Chains

iQIYI Partners with PubMatic for Programmatic Technology Solutions

Topicus.com Inc. Announces Release Date for Second Quarter Results

AIM ImmunoTech Issues Notice that an Unaffiliated Third Party and Organization are Providing False Information Related to Relationship with Company and its Affiliates

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice